NCT07920588
STRONG: SMART Trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (5)
Arms and interventions
This arm includes participants assigned to STRONG group prenatal care in Stage 1 who do not develop gestational diabetes mellitus (GDM) at 24-28 weeks of gestation. In Stage 1, participants receive culturally adapted group prenatal care combining routine clinical assessment with facilitated education, goal setting, self-monitoring, and peer support. In Stage 2, participants without GDM continue STRONG prenatal care without additional GDM-specific education or counseling.
This arm includes participants assigned to usual prenatal care in Stage 1 who do not develop Gestational Diabetes Mellitus (GDM) at 24-28 weeks of gestation. In Stage 1, participants receive standard individual prenatal care through participating healthcare facilities in American Samoa. In Stage 2, participants without GDM continue usual prenatal care without additional GDM-specific education or counseling.
This arm includes participants assigned to STRONG group prenatal care in Stage 1 who develop Gestational Diabetes Mellitus (GDM) at 24-28 weeks and are subsequently randomized to group-based GDM education. In Stage 1, participants receive STRONG group prenatal care. In Stage 2, participants continue their assigned prenatal care and receive additional group-based GDM education emphasizing diabetes self-management, nutrition, physical activity, blood glucose monitoring, and peer support. All clinical GDM treatment remains under the direction of their healthcare providers.
This arm includes participants assigned to STRONG group prenatal care in Stage 1 who develop Gestational Diabetes Mellitus (GDM) at 24-28 weeks and are subsequently randomized to usual individual GDM counseling. In Stage 1, participants receive STRONG group prenatal care. In Stage 2, participants continue their assigned prenatal care and receive usual one-on-one GDM counseling through local healthcare services, including individualized nutrition and diabetes self-management advice as clinically indicated.
This arm includes participants assigned to usual prenatal care in Stage 1 who develop Gestational Diabetes Mellitus (GDM) at 24-28 weeks and are subsequently randomized to group-based GDM education. In Stage 1, participants receive standard individual prenatal care through participating healthcare facilities. In Stage 2, participants continue usual prenatal care and receive additional group-based GDM education emphasizing diabetes self-management, nutrition, physical activity, blood glucose monitoring, and peer support. All clinical GDM treatment remains under the direction of their healthcare providers.
This arm includes participants assigned to usual prenatal care in Stage 1 who develop Gestational Diabetes Mellitus (GDM) at 24-28 weeks and are subsequently randomized to usual individual GDM counseling. In Stage 1, participants receive standard individual prenatal care through participating healthcare facilities. In Stage 2, participants continue usual prenatal care and receive usual one-on-one GDM counseling through local healthcare services, including individualized nutrition and diabetes self-management advice as clinically indicated.
Behavioral: STRONG Group Prenatal Care, Usual Prenatal Care, Group-Based Gestational Diabetes Education, Usual Individual Gestational Diabetes Counseling
Sites
1 site in 1 country
- Yale OLaGA Research CenterNu‘uuli, Pago Pago, American Samoa